Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Publication year range
1.
Drug Deliv ; 21(7): 519-29, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24245857

ABSTRACT

The aims of the present study were to prepare new dual-mode floating gastroretentive tablets (DF-GRT) containing itraconazole (ITR) and to evaluate influence of the dosage forms on pharmacokinetic parameters of ITR. The solubility of ITR was enhanced around 200 times (from 1.54 to 248.38 µg/mL) by preparing solid dispersion (SD) with hydroxypropylmethyl cellulose. Buoyancy of DF-GRT containing ITR-SD was established by both camphor sublimation and gas generation. Camphor sublimation decreased density of DF-GRT by making pores in tablet matrix, which led to elimination of lag time for floating. Carbon dioxide generated by sodium bicarbonate and citric acid helped to maintain buoyancy of DF-GRT. Therefore DF-GRT floated on the medium without lag time until disintegrated entirely during in vitro release study. They released 89.11% of the drug at 2 h. Residual camphor was <0.5 wt% after sublimation. The pharmacokinetics of DF-GRT was evaluated in six miniature pigs and compared to immediate release tablets (IRT). Mean AUC ratio of GRT/IRT was 1.36 but there was no statistical difference between AUC values. However delayed tmax, increased MRT and equivalent Cmax of DF-GRT supposed it could be a promising tool for gastroretentive drug delivery system containing ITR.


Subject(s)
Drug Carriers/chemical synthesis , Drug Carriers/metabolism , Drug Delivery Systems/methods , Itraconazole/blood , Itraconazole/chemical synthesis , Animals , Camphor/blood , Camphor/chemical synthesis , Delayed-Action Preparations/chemical synthesis , Delayed-Action Preparations/metabolism , Drug Evaluation, Preclinical/methods , Solubility , Swine , Swine, Miniature , Tablets
2.
Chem Pharm Bull (Tokyo) ; 61(4): 371-8, 2013.
Article in English | MEDLINE | ID: mdl-23385960

ABSTRACT

Doxazosin mesylate (DXM) sustained release pellets were prepared by an extrusion-spheronization and fluid-bed coating technique. The core pellets containing DXM were prepared by extrusion-spheronization technique, and coated by a fluid-bed coater to control the release of DXM. The factors affecting to properties of pellets, such as diluent content, type and coating level of coating agents and plasticizers were studied in the present study. Polymethacrylate derivatives (Eudragit® RS PO and RL PO) were used for coating agents, and polyethylene glycol 6000 (PEG 6000), triethyl citrate (TEC) and castor oil were as plasticizers. To evaluate the properties of prepared pellets, the size of prepared pellets was investigated by sieve analysis technique and the morphology of pellets was evaluated by scanning electron microscopy. Through the dissolution test, factors that have an effect on the dissolution of the drug were evaluated. As the content ratio of microcrystalline cellulose (MCC) had increased, the dissolution was proportionally sustained. Eudragit® RS PO had more marked sustaining effect on the dissolution rate than Eudragit® RL PO, and the effect was more pronounced with the increased coating level. PEG 6000 was an appropriate plasticizer for DXM pellets, and increasing the content of PEG 6000, was also slightly decreasing the dissolution rate.


Subject(s)
Doxazosin/metabolism , Microscopy, Electron, Scanning , Castor Oil/chemistry , Cellulose/chemistry , Citrates/chemistry , Doxazosin/chemistry , Kinetics , Particle Size , Plasticizers/chemistry , Polyethylene Glycols/chemistry , Polymethacrylic Acids/chemistry
3.
Drug Dev Ind Pharm ; 39(6): 836-44, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22510064

ABSTRACT

This study was conducted primarily to improve the solubility of rebamipide, a poorly water-soluble anti-ulcer drug, using novel ternary solid dispersion (SD) systems and secondly to evaluate the effect of solubility enhancement on its pharmacokinetic (PK) and pharmacodynamic (PD) profile. After dissolving the three components in aqueous medium, ternary SD containing the drug, sodium hydroxide (NaOH) and PVP-VA 64 was achieved by spray drying method, which was used as primary SD. Poloxamer 407, a surfactant polymer, was incorporated in this primary SD by four different methods: co-grinding, physical mixing, melting or spray drying. SD was then characterized by dissolution test, differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD) and Fourier transform infrared spectroscopy (FT-IR). The spray dried SD of poloxamer 407 together with primary SD displayed highest dissolution rate of the drug of about 70% after 2 h. DSC, PXRD and FT-IR characterized the amorphous state and molecular dispersion of the drug in the SD. PK and PD studies in Sprague-Dawley rats revealed that the bioavailability of the drug using optimal SD was about twofold higher than that of reference product, and the irritation area of stomach was significantly reduced in the ulcer-induced rat model using optimal SD as compared to the reference product.


Subject(s)
Alanine/analogs & derivatives , Anti-Ulcer Agents/chemistry , Anti-Ulcer Agents/pharmacokinetics , Poloxamer/chemistry , Poloxamer/pharmacokinetics , Quinolones/chemistry , Quinolones/pharmacokinetics , Alanine/chemistry , Alanine/pharmacokinetics , Animals , Chemical Phenomena , Drug Evaluation, Preclinical/methods , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Male , Rats , Rats, Sprague-Dawley , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL